M
MedSynergies
Revenue cycle management and consulting services for physicians, central billing executives, and hospital executives
About MedSynergies
MedSynergies, established in 1996, operates as a technology-enabled health services company focused on the financial and operational needs of healthcare organizations. The company was founded by a group of physicians. John R. "J.R." Thomas, who had a background in corporate finance at predecessors of J.P. Morgan Chase and Bank One, was a key figure from the early stages, serving as CEO. His financial expertise was instrumental in guiding the company's growth and strategic direction.
The firm specializes in providing a comprehensive suite of services aimed at improving the business side of healthcare for its clients, which primarily include physician groups and large hospital systems. MedSynergies' business model is centered on forming partnerships with these healthcare organizations to align and manage their operations. Revenue is generated through its services, which include revenue cycle management (RCM), practice management, billing and collections, business process analysis, and software integration. The core of its offering is to optimize the entire revenue process, from patient scheduling and physician billing to payment processing and collections, thereby improving financial performance and allowing providers to focus on patient care.
The company's services are designed to handle the complex administrative and financial tasks associated with healthcare delivery. This includes managing billing for over 56 specialties, patient referral management, and providing analytics to enhance practice performance. By integrating technology and process optimization, MedSynergies helps its partners increase cash flow and reduce operational costs. A significant milestone in the company's history was its acquisition by Optum, a division of UnitedHealth Group, in October 2014. This acquisition was a strategic move for Optum to expand its service offerings to physician practices and create end-to-end capabilities across clinical, ambulatory, and acute care settings. At the time of the acquisition, MedSynergies was serving more than 9,300 care providers across the United States.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Sep 2014 | $0 | — | UnitedHealth Group | — |
| GROWTH EQUITY VCOther financing | Jul 2013 | $65M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for MedSynergies is 200 monthly website visits. MedSynergies's team declined 18.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
MedSynergies in the Irving ecosystem
The MedSynergies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
FTV Capital
Other known investors1 additional known investor
UnitedHealth Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MedSynergies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MedSynergies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








